| http://www.w3.org/ns/prov#value | - ???Tenofovir DF therapy was well tolerated and effective in suppressing HBV in adolescents,??? concludes Dr. Murray. ???Our trial demonstrates that tenofovir is a beneficial therapy for managing chronic HBV in teens.??? The authors note that a two-year open-label phase study will further investigate the sustained response and safety of tenofovir DF.
|
